Friday, 18 April 2014 08:42

Qualification of New Translational Kidney Safety Biomarkers for Drug Development

By  Frank Sistare
Rate this item
(0 votes)

This presentation was given by Frank Sistare on behalf of the FNIH Biomarkers Consortium KSP Team. It was given during the ISN Nexus Symposium 2014 held in Bergamo, Italy on April 3-6, 2014. The focus this year was on the New era of drug discovery and clinical trials in kidney disease.

 

Additional Info

  • Language: English
  • Contains Audio: No
  • Content Type: Presentations
  • Source: ISN
  • Event: Nexus
  • Year: 2014
  • Members Only: No
Read 3596 times

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact